BE856937A - Compositions pharmaceutiques actives sur le systeme nerveux central - Google Patents
Compositions pharmaceutiques actives sur le systeme nerveux centralInfo
- Publication number
- BE856937A BE856937A BE179459A BE179459A BE856937A BE 856937 A BE856937 A BE 856937A BE 179459 A BE179459 A BE 179459A BE 179459 A BE179459 A BE 179459A BE 856937 A BE856937 A BE 856937A
- Authority
- BE
- Belgium
- Prior art keywords
- pharmaceutical compositions
- nervous system
- central nervous
- compositions active
- active
- Prior art date
Links
- 210000003169 central nervous system Anatomy 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7622045A FR2358881A1 (fr) | 1976-07-20 | 1976-07-20 | Composition pharmaceutique active sur le systeme nerveux central |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE856937A true BE856937A (fr) | 1978-01-19 |
Family
ID=9175888
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE179459A BE856937A (fr) | 1976-07-20 | 1977-07-19 | Compositions pharmaceutiques actives sur le systeme nerveux central |
Country Status (3)
| Country | Link |
|---|---|
| BE (1) | BE856937A (enExample) |
| FR (1) | FR2358881A1 (enExample) |
| ZA (1) | ZA774376B (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5231099A (en) * | 1991-04-15 | 1993-07-27 | Du Pont Merck Pharmaceutical Company | Use of sigma receptor antagonists to enhance the effects of antipsychotic drugs |
-
1976
- 1976-07-20 FR FR7622045A patent/FR2358881A1/fr active Granted
-
1977
- 1977-07-19 BE BE179459A patent/BE856937A/xx not_active IP Right Cessation
- 1977-07-20 ZA ZA00774376A patent/ZA774376B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR2358881B1 (enExample) | 1980-10-03 |
| ZA774376B (en) | 1978-06-28 |
| FR2358881A1 (fr) | 1978-02-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BE852444A (fr) | Compositions pharmaceutiques anti-inflammatoires | |
| NL7902778A (nl) | Cerebraal werkzaam preparaat. | |
| SE7709359L (sv) | Farmaceutisk doseringsform | |
| BE851590A (fr) | Compositions pharmaceutiques renfermant des pyrethrinoides | |
| IT7830708A0 (it) | Composti farmacologicamente attivi. | |
| IT7919107A0 (it) | Composti farmacologicamente attivi. | |
| NL7600906A (nl) | Farmacologisch actieve verbindingen. | |
| NO770957L (no) | Piperidinforbindelser for orale preparater. | |
| FI773568A7 (fi) | Farmaceutiska preparat med laongtidsverkan | |
| NL980017I1 (nl) | Anti-hypertensief oraal farmaceutisch preparaat. | |
| DK408577A (da) | Indgivelsessaet | |
| NL7714432A (nl) | 1-gesubstitueerde-3-aminoethoxypyrrolidinen met geneeskrachtige activiteit. | |
| NL7613093A (nl) | Farmacologisch actieve verbindingen. | |
| NL7705561A (nl) | Farmaceutisch preparaat en werkwijzen voor de bereiding en toepassing ervan. | |
| NL7708379A (nl) | Farmacologisch actieve verbindingen. | |
| IT7828531A0 (it) | (omega-amminoalcossi) dibenzili farmaceuticamente attivi. | |
| DD128671A5 (de) | Pharmazeutische mittel | |
| NL7708916A (nl) | Inrichting voor meervoudige dosering. | |
| NL7805158A (nl) | Farmaceutisch preparaat. | |
| NL7705560A (nl) | Farmaceutisch preparaat. | |
| NL7614500A (nl) | Montmorilloniet bevattende farmaceutische preparaten. | |
| NL7812344A (nl) | Farmaceutisch preparaat. | |
| SE7607120L (sv) | Dosinstellare | |
| NL7709334A (nl) | Carcinostatisch preparaat. | |
| BE804205A (fr) | Nouvelle preparation active sur le systeme nerveux central |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RE | Patent lapsed |
Owner name: SYNTHELABO Effective date: 19840719 |